Michael Secora
Chief Financial Officer · RECURSION PHARMACEUTICALS, INC.
- 2024
- Nov 19, 2024
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Secora files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Blake Borgeson - $3.38M in RXRX purchases and sales in the last 12 months
- Christopher Gibson - $2.41M in RXRX purchases and sales in the last 12 months
- Najat Khan - $258K in RXRX purchases and sales in the last 12 months
- Robert Hershberg - $125K in RXRX purchases and sales in the last 12 months
- Ben R. Taylor - $68K in RXRX purchases and sales in the last 12 months
- Namandje Bumpus - $28K in RXRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Secora?
Michael Secora is a corporate insider, tracked as Chief Financial Officer of RECURSION PHARMACEUTICALS, INC. (RXRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Michael Secora last file a Form 4?
The most recent primary Form 4 on record is dated 19 November 2024, one of 3 filings going back to 2024.
Has Michael Secora been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($420K) across all tracked filings.
